Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RSH-7 is a potent dual inhibitor of BTK and FLT3, with IC50s of 47 and 12 nM, respectively.RSH-7 has antiproliferative and antitumor activities, inducing apoptosis and inhibiting BTK and FLT3 signaling.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 263.00 | |
10 mg | In stock | $ 428.00 | |
25 mg | In stock | $ 813.00 | |
50 mg | In stock | $ 1,180.00 | |
100 mg | In stock | $ 1,620.00 | |
500 mg | In stock | $ 3,230.00 |
Description | RSH-7 is a potent dual inhibitor of BTK and FLT3, with IC50s of 47 and 12 nM, respectively.RSH-7 has antiproliferative and antitumor activities, inducing apoptosis and inhibiting BTK and FLT3 signaling. |
Targets&IC50 | BTK:47 nM, FLT3:12 nM |
In vitro |
RSH-7 (1-1000 nM; 72 h) exhibits antiproliferative activities for Jeko-1, MV-4-11, Molt4, and K562 cells with IC50 values of 17 nM, 3 nM, 11 nM, and 930 nM respectively.[1] RSH-7 (1-1000 nM; 72 h) dose-dependently reduces the expression of p-BTK (TYR223), p-PLCγ(Tyr1217), p-FLT3 (Tyr589), and p-STAT5 (TYR694).[1] RSH-7 (1-1000 nM; 72 h) dose-dependently triggers apoptosis and upregulates the expression of BAX, p53, and cleaved caspase 3 in Jeko-1 cells.[1] |
In vivo | RSH-7 (25, 50 mg/kg; i.p.; daily for 16 days; Female NOD/SCID mice) suppressed tumor growth in a dose-dependent manner, with tumor growth inhibition (TGI) values of 66.95% and 79.78% at doses of 25 and 50 mg/kg.[1] |
Molecular Weight | 436.49 |
Formula | C22H25FN8O |
CAS No. | 2764609-97-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 75 mg/mL (171.83 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RSH-7 2764609-97-2 Angiogenesis Apoptosis Tyrosine Kinase/Adaptors BTK FLT inhibitor inhibit